Your browser doesn't support javascript.
loading
Interleukin 6 as an energy allocator in muscle tissue.
Kistner, Timothy M; Pedersen, Bente K; Lieberman, Daniel E.
Affiliation
  • Kistner TM; Department of Human Evolutionary Biology, Harvard University, Cambridge, MA, USA. tkistner@g.harvard.edu.
  • Pedersen BK; Centre of Inflammation and Metabolism/Centre for Physical Activity Research (CIM/CFAS), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Bente.Klarlund.Pedersen@regionh.dk.
  • Lieberman DE; Department of Human Evolutionary Biology, Harvard University, Cambridge, MA, USA. danlieb@fas.harvard.edu.
Nat Metab ; 4(2): 170-179, 2022 02.
Article in En | MEDLINE | ID: mdl-35210610
Extensive research has shown that interleukin 6 (IL-6) is a multifunctional molecule that is both proinflammatory and anti-inflammatory, depending on the context. Here, we combine an evolutionary perspective with physiological data to propose that IL-6's context-dependent effects on metabolism reflect its adaptive role for short-term energy allocation. This energy-allocation role is especially salient during physical activity, when skeletal muscle releases large amounts of IL-6. We predict that during bouts of physical activity, myokine IL-6 fulfills the three main characteristics of a short-term energy allocator: it is secreted from muscle in response to an energy deficit, it liberates somatic energy through lipolysis and it enhances muscular energy uptake and transiently downregulates immune function. We then extend this model of energy allocation beyond myokine IL-6 to reinterpret the roles that IL-6 plays in chronic inflammation, as well as during COVID-19-associated hyperinflammation and multiorgan failure.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / COVID-19 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Metab Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / COVID-19 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Metab Year: 2022 Document type: Article Affiliation country: Country of publication: